Details of the Drug

General Information of Drug (ID: DMW0IRA)

Drug Name

PLX-PAD cell therapy

Indication

Disease Entry	ICD 11	Status	REF
Critical limb ischemia	BD4Y	Phase 3	[1]
Peripheral vascular disease	BD4Z	Phase 2	[2]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT01679990) Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC). U.S. National Institutes of Health.